Credit: Alcon. The active ingredient in Tryptyr is acoltremon, an agonist of transient receptor potential melastatin 8 thermoreceptors. Tryptyr significantly improved tear production compared with ...

In pivotal Phase 3 trials, TRYPTYR demonstrated rapid natural tear production as early as Day 1 1-2 TRYPTYR is a first-in-class TRPM8 receptor agonist that rapidly stimulates natural tear ...

has approved TRYPTYR® (acoltremon ophthalmic solution) 0.003%, formerly known as AR-15512, for the treatment of signs and symptoms of Dry Eye Disease (DED).3 TRYPTYR is a first-in-class TRPM8 ...

DED is a complex, multifactorial condition driven by a deficiency in natural tears, whether due to decreased tear production or increased tear evaporation.5-7 Many commonly used DED treatment ...

In pivotal Phase 3 trials, TRYPTYR demonstrated rapid natural tear production as early as Day 1 1-2 TRYPTYR is a first-in-class TRPM8 receptor agonist that rapidly stimulates natural tear production ...

Khindivi is expected to be available the week of June 2, 2025. Khindivi is the first FDA-approved hydrocortisone oral solution. The Food and Drug Administration (FDA) has approved Khindivi ...

The district attorney's office drops investigation into jailbreak as the attorney general's office opens up its investigation into operation failures. District Attorney Jason Williams is standing ...

A Tottenham star has thanked fans for their “love and support” in what seemed like a farewell message after feeling he became “part of history” of the club. Spurs won their first major ...

After years of anticipation, WhatsApp may finally be gearing up to launch a dedicated app for iPad users. The Meta-owned messaging giant has dropped a subtle hint that has reignited speculation ...